Regulation of airway eosinophil and neutrophil infiltration by α-galactosylceramide in a mouse model for respiratory syncytial virus (RSV) vaccine-augmented disease

This publication has 30 references indexed in Scilit:

• Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals
  Proceedings of the National Academy of Sciences, 2007
• IL-13 is associated with reduced illness and replication in primary respiratory syncytial virus infection in the mouse
  Microbes and Infection, 2006
• Modulation of Protective Immunity, Eosinophilia, and Cytokine Responses by Selective Mutagenesis of a Recombinant G Protein Vaccine against Respiratory Syncytial Virus
  Journal of Virology, 2005
• Role of CCL11 in Eosinophilic Lung Disease during Respiratory Syncytial Virus Infection
  Journal of Virology, 2005
• Respiratory Syncytial Virus–Induced Chemokine Production: Linking Viral Replication to Chemokine Production In Vitro and In Vivo
  The Journal of Infectious Diseases, 2004
• CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung
  Nature Medicine, 2002
• Natural Killer T Cell Ligand α-Galactosylceramide Enhances Protective Immunity Induced by Malaria Vaccines
  The Journal of Experimental Medicine, 2002
• Liposome encapsulation of a soluble recombinant fragment of the respiratory syncytial virus (RSV) G protein enhances immune protection and reduces lung eosinophilia associated with virus challenge
  Vaccine, 2000
• Immunization with α-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis
  European Journal of Immunology, 1999
• MOUSE CD1-SPECIFIC NK1 T CELLS: Development, Specificity, and Function
  Annual Review of Immunology, 1997